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Methylmalonic Acidemia: Diagnosis and Neuroimaging Findings of This 
Neurometabolic Disorder (An Iranian Pediatric Case Series)
Abstract
Objective
Methylmalonic acidemia is one of the inborn errors of metabolism resulting 
in the accumulation of acylcarnitine in blood and increased urinary 
methylmalonic acid excretion. This disorder can have symptoms, such as 
neurological and gastrointestinal manifestations, lethargy, and anorexia. 
Materials & Methods
The patients who were diagnosed as methylmalonic acidemia in the 
Neurology Department of Mofid Children’s Hospital in Tehran, Iran, between 
2002 and 2012 were included in our study. The disorder was confirmed by 
clinical findings, neuroimaging findings, and neurometabolic and genetic 
assessment in reference laboratory in Germany. We assessed the age, gender, 
past medical history, developmental status, clinical manifestations, and 
neuroimaging findings of 20 patients with methylmalonic acidemia. 
Results
Eighty percent of the patients were offspring of consanguineous marriages. 
Half of the patients had Failure to thrive (FTT) due to anorexia; 85% had 
history of developmental delay or regression, and 20% had refractory 
seizure, which all of them were controlled. The patients with methylmalonic 
acidemia were followed for approximately 5 years and the follow-up showed 
that the patients with early diagnosis had a more favorable clinical response 
in growth index, refractory seizure, anorexia, and neurodevelopmental delay. 
Neuroimaging findings included brain atrophy, basal ganglia involvement 
(often in putamen), and periventricular leukomalacia.
Conclusion
According to the results of this study, we suggest that early assessment and 
diagnosis have an important role in the prevention of disease progression 
and clinical signs.
Keywords: Methylmalonic acidemia; Neurometabolic disorder; 
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Introduction
Methylmalonic acidemia is a rare inborn neurometabolic disorder with error 
in aminoacid metabolism (1). This disorder is caused by decrease in activity of 
methylmalonyl-coA mutase. This enzyme is necessary for catabolism of four amino 
acid (isoleucine, methionine, threonine, valine) (2,3). Methylmalonic acidemia can 
present with neurologic deficits, metabolic acidosis, vomiting, lethargy, anorexia, 
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old patient. The average age of patients at detection time 
was 31.5 months. Twenty-five percent of the patients 
had a history of neonatal hospitalization because of 
prematurity (10% of patients) and icter (15% of patients). 
In developmental assessment, 50% of patients had 
developmental delay, 15% had normal development, but 
20% of these patients showed developmental delay and 
regression due to stress, such as infection and fever; and 
15% of patients had a normal developmental assessment. In 
the patients who had a normal developmental assessment, 
the head circumference and neuroimaging were normal 
because our survey were done on siblings of our patients 
with methylmalonic acidemia. Thirty-six percent of the 
patients had a history of recurrent vomiting and narcosis 
attack. One of the patients had a complaint of halitosis and 
undescended testis (UDT). Forty-five percent of patients 
had a dysmorphic face with protruding forehead and 
depressed nasal bridge; one patient had polydactyly; three 
patients had maculopapular lesions and thin hair; and one 
patient had hepatomegaly.
Eighty percent of patients were offspring of consanguineous 
marriages, so that in 50% of patients, their parents were 
first cousins and in 15%, their parents were second 
cousins, 15% of patients’ parents were family relatives, 
not first or second cousin. Thirty-six percent of patients 
had a family history of seizure, developmental delay, or 
death in their children. Weight in 50% of patients was 
below the 3% percentile, and height in 10% of patients 
was below the 5% percentile. 
Forty-five percent of patients had microcephaly, 10% had 
macrocephaly, and 45 % had normal head circumference. 
Fundoscopic examination in all patients was normal, 
but 10% of patients had intermittent gaze to one side. 
Twenty-five percent of patients had spastic; 30% had 
hypotonicity; 20% had brisk DTR; 60% had a history of 
seizure (30% tonic, 20% GTC, and 10% infantile spasm); 
20% had refractory seizure, that all types of refractory 
seizure were controlled after diagnosis and treatment 
of methylmalonic academia; and 20% of patients had 
agitation and irritability. No abnormality was observed in 
other physical examinations (chest and abdomen).
In lab data, 50% of patients had decreased levels of 
hemoglobin, 33% had cytopenia; 15 % had increased 
levels of ammonia, 20% had increased levels of lactate, 
and 25% had metabolic acidosis, and one patient had 
respiratory distress, severe ketoacidosis, and hypotonia. If 
this disorder is not treated immediately, the patient may 
go into coma and die (4-6). Increased organic acid level, 
such as methylmalonic acid may be toxic and harmful 
for all types of body cells (7). Organs involvement in 
methylmalonic acidemia includes central nervous system 
(CNS), bone marrow and kidneys (8). In this study, we 
present 10 years of experience about methylmalonic 
academia in the Pediatric Neurology Research Center 
of Mofid Children’s Hospital, Tehran, Iran. We describe 
clinical symptoms and neuroimaging findings of 20 cases 
with this disorder.
Materials & Methods
This observational study was performed on patients 
who were diagnosed as methylmalonic acidemia in the 
Neurology Department of Mofid Children’s Hospital 
in Tehran, Iran, between 2002. The diagnosis was 
performed based on clinical manifestations, neuroimaging 
findings, and finally laboratory assessment of increased 
acylcarnitine level in blood and methylmalonic acid 
level detection in urine at metabolic disorders laboratory 
in Germany. The data of the patients were collected as 
age, gender, past medical history, developmental status, 
general appearance, and clinical and neuroimaging 
findings. 
Treatment consisted of cobalamin and carnitine 
supplements and a low-protein diet. The children’s diet 
was carefully controlled. If supplements did not help, the 
doctor could also recommend a diet that avoids, substances 
such as isoleucine, threonine, methionine, and valine.
The data were analyzed by descriptive method and no 
statistical testing was applied.
Institutional ethical approval for the conduct of this study 
was obtained from the Pediatric Neurology Research 
Center of Shahid Beheshti University of Medical Sciences, 
Tehran, Iran. All parents signed a written consent for 
participation in the study.
Results
Twenty patients with Methylmalonic acidemia were 
included in this study. They were 10 males and 10 females 
and their age range was from 3.5 months to 15.6 months. 
The earliest case was diagnosed in a patient who was 2 
months old and the latest case was diagnosed in a 2 year-
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were done about them. Another reason for this difference 
in the percentage of reported seizure may be related to 
high frequency of consanguineous marriage between the 
patients’ parents in our study.
In all our patients with normal development, head 
circumference, and neuroimaging were normal. The 
patients were the siblings with methylmalonic acidemia 
that our survey was done on them in order to prevention 
of neurological symptoms and signs, early diagnosis, 
and treatment. Fifty percent of patients had brain 
atrophy, 15% had basal ganglia involvement (mostly in 
putamen), 10% had PVL (periventricular leukomalacia), 
and 30% had normal brain MRI. In 3 patients, EEG 
showed BURST suppression. In Brismar et al.’s study, 
mild to moderate myelination delay and basal ganglia 
changes, especially in globus pallidus were reported (11). 
In a study by Nicolaides et al. there was reported that 
seizure, hypotonicity, movement disorders, spasticity, 
developmental delay, and mental retardation were the 
manifestations of methylmalonic academia (12). 
In a study by Radmanesh et al. on 52 patients (71.2% 
male and 28.8% female) with methylmalonic academia, 
cortical atrophy and ventricular dilation were observed in 
their neuroimaging. The first presentation of their patients 
were seizure, developmental delay, hypotonicity, and 
respiratory and gastrointestinal symptoms (3).
In conclusions, twenty-five percent of our patients 
had a history of hospitalization at birth. Eighty percent 
of patients were offspring of consanguineous marriage, 
which is an important point to be considered in patients 
with suspected neurometabolic disorders. There were 
3 patients with cutaneous manifestations and thin hair 
who were similar to patients with other neurometabolic 
disorders. The incidence of neurological disorders such as 
developmental delay and regression was found in 85% of 
patients and seizure was seen in 60% of patients, which 
this incidence is more than that of other studies. Most 
patients with normal development, head circumference, 
and neuroimaging were siblings of methylmalonic 
acidemia patients that had been analyzed in term of 
methylmalonic acidemia. Twenty percent of patients had 
refractory seizure, that all types of seizure were controlled 
after the treatment of methylmalonic acidemia.
Acknowledgments
nephritis and proteinuria, and one another patient had 
chronic renal failure with increased levels of Cr. In 
addition to methylmalonic academia, three patients had 
propionic acidemia and one patient had homocystinuria.
Electroencephalography (EEG) in 3 patients showed 
BURST suppression. In neuroimaging data, 50% of 
patients had brain atrophy, 15% had basal ganglia 
involvement (mostly in putamen), 10% had periventricular 
leukomalacia (PVL), and 30% had normal brain MRI. 
Discussion
Methylmalonic acidemia is a neurometabolic disorders 
with autosomal recessive inheritance, which is caused by 
methylmalonyl-CoA mutase deficiency. Twenty patients 
(10 males and 10 females) with methylmalonic acidemia 
were included in this study. Twenty-five percent of 
patients had a history of hospitalization because of icter or 
prematurity. Eighty percent of cases had consanguineous 
parents, therefore, in suspected cases of methylmalonic 
acidemia, having consanguineous parents can contribute 
to the diagnosis. Half of the patients had FTT (weight 
bellow 3% percentile) because of anorexia, that percentiles 
of weight and height were improved after the treatment of 
methylmalonic acidemia. Forty-five percent of patients 
had microcephaly, 10% had macrocephaly, and 45% had 
normal head circumference; therefore, the macrocephaly 
and microcephaly and normal head circumference have 
not any profit and loss in the diagnosis. Three patients had 
skin lesions and thin hair, so that their appearance was 
similar to that of biotinidase-deficient patients. Eight-five 
percent of patients had a history of developmental delay 
and regression and evolution only in 15% of patients 
was normal. Twenty percent of patients had a history of 
sever agitation and 60% of them had a history of seizure 
(30% tonic, 20% GTC, and 10% infantile spasm). Twenty 
percent of the patients had refractory seizure, that all types 
of refractory seizure were controlled after diagnosis and 
treatment of methylmalonic acidemia. Seizure detection 
in our study was more than previous studies. Ma et al. 
reported seizure in 42.9% of their patients (10). The 
reason of our high reports of seizure detection, especially 
infantile spasm, probably is our attention to non-specific 
presentation and features of seizure (especially infantile 
spasm). Our patients with methylmalonic acidemia and 
seizure came to our specialist center and exact evaluations 
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